JM Giltnane, MD, PhD

🧬Physician-scientist 🤖 computational pathology 🚀spatial biology👩🏻‍🔬cancer research 🔬 diagnostic tissue assays

[JM Giltnane, MD, PhD @labmedpath]

When I started working in science, HER2+ breast cancer had the worst prognosis. Targeted therapies turned that around and many patients show complete response to neoadjuvant combos. Truly honored to work at Genentech with Gail and others that made these l…https://t.co/E38vG4s8hv

[JM Giltnane, MD, PhD @labmedpath]

@nigeljamieson @CR_AACR @LabSpatialNBJ @LabEdwards @ColinWSteele @grisurgery @UofGMVLS @CR_UK @UofGCancerSci @drcolinwood @nanostringtech Beautiful cover; impressive work - congrats!

[JM Giltnane, MD, PhD @labmedpath]

Really grateful for the time to travel to Boston and the connections made while there! I enjoyed the panel with @PathAI and the opportunity to wave my “Let’s transform Pathology!” flag. https://t.co/LUxyoOMV6Z

[JM Giltnane, MD, PhD @labmedpath]

We're hiring!
https://t.co/qBJprTcox3

Digital & Spatial Pathology section of Genentech Research & Early Development is hiring a pathologist and/or scientist. The position will be focused on enabling the digital transformation of our pathology strategies,…https://t.co/EdWEjZIYMp

[JM Giltnane, MD, PhD @labmedpath]

Join our team! https://t.co/njnbI2VXU4

[JM Giltnane, MD, PhD @labmedpath]

Digital pathology experts: what ontology standards are you utilizing?

[JM Giltnane, MD, PhD @labmedpath]

https://t.co/8KeQl3siia

[JM Giltnane, MD, PhD @labmedpath]

When we all work together to move new technologies forward, patients benefit. #digitalpathology #personalizedhealthcare https://t.co/MwKtWD0QAo

[JM Giltnane, MD, PhD @labmedpath]

#hiringnow https://t.co/OtTiVupuIr

[JM Giltnane, MD, PhD @labmedpath]

Genentech's Translational Tissue Technology (T3) lab collaborated with Hartmut Koeppen Namrata Srivastava Patil and others on this manuscript, investigating the role of plasma cells and tertiary lymphoid structures in #immunotherapy
Join our team! We ar…https://t.co/Dyzvh95H3t

[JM Giltnane, MD, PhD @labmedpath]

We’re #hiring for a talented wet lab researcher at Genentech, focused on advancing our capabilities in #digitalpathology and #spatialtranscriptomics - join us! https://t.co/uucUWAHfI7

[JM Giltnane, MD, PhD @labmedpath]

Great opportunity for graduate students in #digitalpathology https://t.co/AJDHmR9GT5

[JM Giltnane, MD, PhD @labmedpath]

The Translational Tissue Technology lab strives to stay ahead of the curve so Genentech scientists have access to the best #technology platforms for generating biological insights and developing the best drugs for our patients. Most of these technologies…https://t.co/iM9uQRAbrU

[JM Giltnane, MD, PhD @labmedpath]

Start the new year with our group! https://t.co/NtdIuwNF8F

[JM Giltnane, MD, PhD @labmedpath]

Come join our Digital Patjology team! https://t.co/cazEnveHrc

[JM Giltnane, MD, PhD @labmedpath]

Great to see these results, demonstrating how AI/ML in pathology that can produce readouts augmenting clinical interpretation of histologic endpoints & impact patient care for NASH! https://t.co/DVu6gZDTq6

[Genentech @genentech]

A deeper understanding of how immune cells interact with tumors can help inform future cancer immunotherapies. In @Cancer_Cell, our scientists Milena Hornburg, Yulei Wang & team describe new biological underpinnings that characterize these interactions. https://t.co/iVOkLXSOYa

[JM Giltnane, MD, PhD @labmedpath]

@GuzmanArocho @LizaMQuintana @XeniaParisi @YuhoOno @BIDMCpath Great example.

[Julia Maués @itsnot_pink]

“What do patients w/ cancer want from their oncologists?”

I know!

👉 Be like @DrEricWiner!

This wonderful doctor makes even a talk on end of life conversations a lovely one!

To a mostly empty room at #sabcs19, he says “the people that are not here definitely should be”.

[Jane @DrJaneCocks]

APA welcomes singular “they” ~

"Writers should use singular “they”: (a) when referring to a generic person whose gender is unknown or irrelevant to the context and (b) when referring to a specific, known person who uses “they” as their pronoun."

https://t.co/454a0k9aBi